Conversion from chronic to episodic migraine in patients treated with erenumab: real-life data from an Italian region.
Raffaele OrnelloAlfonsina CasalenaIlaria FrattaleValeria CaponnettoAmleto GabrieleGiannapia AffaitatiMaria Adele GiamberardinoMaurizio AssettaMaurizio MaddestraFabio MarzoliStefano ViolaDavide CeroneCarmine MariniFrancesca PistoiaSimona SaccoPublished in: The journal of headache and pain (2020)
In our study, two thirds of patients with CM converted to EM during 6 months of treatment with erenumab. MHDs, acute medication use, and headache intensity decreased regardless of conversion from CM to EM.